私がどこを間違えたのか?

Same author

SABR-5 Results Are Not Reliable in Assessing Improvement or Maintenance of Quality of Life Without Comparable Evaluation in Control Patients.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Same author

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022

Same author

NICE Guidelines: management of colorectal cancer metastases.

The British journal of surgery·2020

Same author

Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020

Same author

Local treatment of 'Oligometastases': Wishful thinking is not supported by available evidence.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020

Same author

An approach to randomization into surgical clinical trials.

The British journal of surgery·2016

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

私がどこを間違えたのか?

関連する概念動画

SABR-5 Results Are Not Reliable in Assessing Improvement or Maintenance of Quality of Life Without Comparable Evaluation in Control Patients.

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence.

NICE Guidelines: management of colorectal cancer metastases.

Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.

Local treatment of 'Oligometastases': Wishful thinking is not supported by available evidence.

An approach to randomization into surgical clinical trials.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

私がどこを間違えたのか?

関連する概念動画

関連記事

SABR-5 Results Are Not Reliable in Assessing Improvement or Maintenance of Quality of Life Without Comparable Evaluation in Control Patients.

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence.

NICE Guidelines: management of colorectal cancer metastases.

Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.

Local treatment of 'Oligometastases': Wishful thinking is not supported by available evidence.

An approach to randomization into surgical clinical trials.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.